We evaluated the impact of CMD‐BHQ3‐PTL/DOX@RBCm treatment on YAP phosphorylation in tumor tissues at the protein and gene expression levels in vivo (Figure 9A,B; Figure S9C, Supporting Information). The gene discussed is YAP1; the disease is neoplasm.